184 related articles for article (PubMed ID: 37332118)
41. Smoking-related epigenetic modifications are associated with the prognosis and chemotherapeutics of patients with bladder cancer.
Ling Y; Li J; Zhou L
Int J Immunopathol Pharmacol; 2023; 37():3946320231166774. PubMed ID: 37011378
[TBL] [Abstract][Full Text] [Related]
42. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
Cai J; Zhou M; Xu J
World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
[TBL] [Abstract][Full Text] [Related]
43. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
[TBL] [Abstract][Full Text] [Related]
44. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
45. RNA N6-Methyladenosine Regulator-Mediated Methylation Modifications Pattern and Immune Infiltration Features in Glioblastoma.
Pan Y; Xiao K; Li Y; Li Y; Liu Q
Front Oncol; 2021; 11():632934. PubMed ID: 33718217
[TBL] [Abstract][Full Text] [Related]
46. m
Zhuang J; Lin C; Ye J
J Cell Physiol; 2020 Sep; 235(9):6300-6306. PubMed ID: 32043594
[TBL] [Abstract][Full Text] [Related]
47. Dysfunctional epigenetic protein-coding gene-related signature is associated with the prognosis of pancreatic cancer based on histone modification and transcriptome analysis.
Yu X; Wang Y; Shi X; Wang Z; Wen P; He Y; Guo W
Sci Rep; 2023 Jan; 13(1):146. PubMed ID: 36599884
[TBL] [Abstract][Full Text] [Related]
48. Integrative Analysis of m
Zhao H; Pan S; Duan J; Liu F; Li G; Liu D; Liu Z
Front Cell Dev Biol; 2021; 9():724837. PubMed ID: 34557492
[TBL] [Abstract][Full Text] [Related]
49. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
[TBL] [Abstract][Full Text] [Related]
50. Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy.
Li J; Liu D; Ren J; Li G; Zhao Z; Zhao H; Yan Q; Duan J; Liu Z
Hum Genomics; 2023 Feb; 17(1):6. PubMed ID: 36765416
[TBL] [Abstract][Full Text] [Related]
51. Uncovering the Association Between m
Gu X; Zhou H; Chu Q; Zheng Q; Wang J; Zhu H
Front Cell Dev Biol; 2021; 9():727935. PubMed ID: 34589490
[No Abstract] [Full Text] [Related]
52. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
Front Oncol; 2020; 10():1119. PubMed ID: 32974125
[No Abstract] [Full Text] [Related]
53. Comprehensive analysis of m
Liu T; Li H; Du G; Ma J; Shen J; Zhao H; Luo F; Li H
Gene; 2022 May; 821():146250. PubMed ID: 35151825
[TBL] [Abstract][Full Text] [Related]
54. RNA N6-Methyladenosine Patterns in Hepatocellular Carcinoma Reveal a Distinct Immune Infiltration Landscape and Clinical Significance.
Zhao H; Zhou Q; Shi C; Shao Y; Ni J; Lou J; Wei S
Med Sci Monit; 2021 Oct; 27():e930994. PubMed ID: 34690344
[TBL] [Abstract][Full Text] [Related]
55. m
Peng C; Xiong F; Pu X; Hu Z; Yang Y; Qiao X; Jiang Y; Han M; Wang D; Li X
Front Immunol; 2023; 14():1326031. PubMed ID: 38187373
[TBL] [Abstract][Full Text] [Related]
56. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
[TBL] [Abstract][Full Text] [Related]
57. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
Zhao M; Shen S; Xue C
Front Immunol; 2022; 13():805967. PubMed ID: 35401564
[TBL] [Abstract][Full Text] [Related]
58. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
59. m
Chai RC; Wu F; Wang QX; Zhang S; Zhang KN; Liu YQ; Zhao Z; Jiang T; Wang YZ; Kang CS
Aging (Albany NY); 2019 Feb; 11(4):1204-1225. PubMed ID: 30810537
[TBL] [Abstract][Full Text] [Related]
60. A newly defined risk signature, consisting of three m
Fan L; Lin Y; Lei H; Shu G; He L; Yan Z; Rihan H; Yin G
Aging (Albany NY); 2020 Sep; 12(18):18453-18475. PubMed ID: 32950970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
